Chronic pain affects roughly 1 in 4 U.S. adults, and its causes extend far beyond a single injury or disease. In 2023, 24.3% of American adults reported chronic pain, with 8.5% experiencing pain severe enough to frequently limit their ability to work or carry out daily activities. What makes chronic pain so complex is that it rarely has one neat explanation. It typically involves a combination of tissue damage, nervous system changes, brain rewiring, genetics, and psychological factors that feed into each other over time.
How Pain Becomes Chronic
Acute pain is your body’s alarm system. You touch a hot stove, nerves fire, and you pull your hand away. That kind of pain has a clear cause and a clear endpoint. Chronic pain is generally defined as pain lasting at least three months that occurs on most days. The critical difference isn’t just duration. In chronic pain, the nervous system itself changes in ways that keep the alarm ringing long after the original threat has passed, or sometimes without any identifiable threat at all.
The shift from acute to chronic pain involves a process called central sensitization, where the spinal cord and brain amplify pain signals far beyond what the situation warrants. Think of it as the volume knob on your pain system getting turned up and stuck there. Several things go wrong at once: the spinal cord becomes more reactive to incoming signals, the brain’s built-in pain-dampening systems stop working properly, and pathways that actually facilitate pain become overactive. The result is that stimuli that shouldn’t hurt (like light pressure on your skin) start to hurt, and stimuli that are mildly painful become excruciating.
Three Categories of Chronic Pain
Pain specialists now recognize three broad types of chronic pain based on what’s driving it, and many people experience more than one at the same time.
Nociceptive pain comes from ongoing tissue damage or inflammation. This is the most intuitive type. Arthritis wears down joint cartilage, and the surrounding tissue stays inflamed. In autoimmune conditions like rheumatoid arthritis, immune cells infiltrate the joint lining and release inflammatory molecules that directly activate pain-sensing nerve endings. As long as the inflammation persists, so does the pain. Conditions like lupus, inflammatory bowel disease, and endometriosis follow similar patterns.
Neuropathic pain results from damage to the nerves themselves. About 30% of nerve pain cases stem from diabetes, which gradually destroys small nerve fibers, particularly in the feet and hands. But hundreds of other conditions cause it too: shingles can leave behind nerve damage that produces burning pain for months or years. HIV, multiple sclerosis, stroke, Parkinson’s disease, spinal nerve compression, tumors pressing on nerves, and physical trauma from surgery or accidents can all injure nerves in ways that produce persistent, often shooting or electric-shock-like pain.
Nociplastic pain is the most recently defined category, and in some ways the most frustrating for patients. It describes pain that arises from altered processing in the nervous system despite no detectable tissue or nerve damage. Fibromyalgia is the classic example. People with nociplastic pain tend to be tender across multiple body regions and are often more sensitive than average to non-painful stimuli like bright lights, strong smells, and loud noises. Fatigue, sleep problems, difficulty concentrating, depression, and anxiety frequently accompany this type of pain. Changes in brain function and structure, immune processing, and peripheral nerve sensitivity all appear to contribute, but no single test can identify the cause.
How Chronic Pain Reshapes the Brain
One of the most significant discoveries in pain science is that chronic pain physically changes the brain’s structure. Brain regions involved in pain processing lose gray matter, the tissue where most of the brain’s nerve cell bodies are concentrated. This shrinkage shows up in areas responsible for attention, emotion regulation, and pain modulation. The longer and more intense the pain, the more pronounced the changes tend to be.
The prefrontal cortex, which helps regulate both thinking and pain, shows reduced gray matter volume in people with chronic pain. This matters because the prefrontal cortex is part of the brain’s system for turning pain signals down. When it shrinks, your ability to cognitively manage pain weakens. The thalamus, a relay station that routes pain signals to the rest of the brain, also loses volume, disrupting how pain information is processed and distributed. The insula, which helps you sense what’s happening inside your body, shows reduced gray matter in conditions like fibromyalgia, chronic low back pain, and migraine.
Deeper brain structures are affected too. The hippocampus, involved in memory and learning, is significantly smaller in chronic pain patients, which may help explain why pain persists even after the original cause resolves. The amygdala, the brain’s threat-detection center, becomes hyperactive and develops altered connections with other regions, amplifying the emotional weight of pain. These changes in the hippocampus and amygdala are also linked to the mood disorders, anxiety, and depression that so often accompany chronic pain. It’s not that the pain makes people sad and anxious as a separate problem. The same brain changes driving the pain are simultaneously disrupting mood regulation.
Genetics and Pain Sensitivity
Not everyone who experiences an injury or illness develops chronic pain, and genetics are part of the reason. One of the best-studied examples involves a gene called COMT, which produces an enzyme that breaks down several brain chemicals, including dopamine and adrenaline. A specific variation in this gene (called Val158Met) alters how efficiently the enzyme works, which directly affects pain sensitivity. People with certain versions of this variant have lower activity in their natural opioid pain-relief system, making them more sensitive to pain from the start.
The COMT gene also influences pain through the adrenaline system. When the enzyme it produces is less active, adrenaline-related receptors become more stimulated, which increases pain sensitivity through a completely separate pathway. Variations in genes affecting serotonin receptors, serotonin transport, and dopamine receptors have also been found more frequently in people with fibromyalgia. These genetic differences don’t guarantee chronic pain, but they can lower the threshold at which someone’s nervous system tips from acute pain into a chronic state.
Surgery as a Trigger
Surgery is one of the more concrete and underappreciated causes of chronic pain. Cutting through tissue inevitably damages some nerves, and in a significant number of cases, that nerve damage produces pain that outlasts the expected recovery period by months or years.
The rates are striking. After limb amputation, 30% to 85% of patients develop chronic post-surgical pain, with about 75% still experiencing pain at 12 months. Around 80% of that pain is neuropathic, coming from the severed nerves themselves (this includes what’s commonly known as phantom limb pain). After mastectomy, 11% to 57% of patients develop chronic pain, with nerve pain accounting for roughly 65% of cases. These aren’t rare complications. They represent a major source of chronic pain that’s often inadequately discussed before procedures.
Psychological Factors That Amplify Pain
Chronic pain is never “just in your head,” but what happens in your head powerfully shapes how much you suffer. The single most important psychological factor is catastrophizing, a pattern of thinking where you magnify the threat of pain, ruminate on it, and feel helpless to control it. In studies of people with musculoskeletal pain, catastrophizing is the strongest predictor of how disabled someone becomes, outweighing the actual degree of physical damage. It’s also a risk factor for developing chronic pain in the first place. People who catastrophize before surgery, for instance, consistently report worse pain outcomes afterward.
The effects are measurable and concrete. High levels of catastrophizing reduce the effectiveness of pain treatments across the board, from topical creams to oral medications to psychological therapies. This doesn’t mean the pain isn’t real. It means that the brain’s interpretation of danger magnifies the pain signal in ways that make it harder for treatments to bring relief.
Social isolation plays a parallel role. Social support acts as a buffer against the worst effects of pain on daily functioning. People with arthritis who report low support from coworkers are significantly more likely to develop depression and work-related disability within 18 months. Partners’ emotional availability matters too: when a partner has an avoidant or anxious attachment style, the person with pain tends to report higher pain levels and lower well-being. Pain doesn’t exist in a vacuum. It exists inside a life, and the quality of that life’s relationships directly shapes the pain experience.
When Multiple Causes Overlap
In practice, chronic pain rarely fits neatly into one box. Someone with rheumatoid arthritis has nociceptive pain from joint inflammation, but over time they may also develop central sensitization that amplifies signals from the joint and spreads pain to areas that aren’t inflamed. A person who had a spinal surgery may have neuropathic pain from nerve damage during the procedure, nociceptive pain from residual tissue problems, and nociplastic pain from a nervous system that has been rewired by months of unrelieved pain. Layer in genetic predisposition, poor sleep, social stress, and catastrophizing, and you have a condition that no single treatment can fully address.
This overlap is why chronic pain so often resists simple fixes. It’s not one thing gone wrong. It’s a convergence of tissue damage, nerve injury, immune activity, brain remodeling, genetic vulnerability, and psychological patterns, each reinforcing the others in a cycle that becomes self-sustaining. Understanding which of these factors are most active in your particular case is what makes the difference between a treatment plan that helps and one that misses the mark entirely.